Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Virtu Financial LLC Has $1.07 Million Stake in BioNTech SE Sponsored ADR $BNTX - Markets Daily
Virtu Financial LLC Has $1.07 Million Stock Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer
Moderna (MRNA) Eyes Manufacturing Facilities in Germany Amid BioNTech Closures
BioNTech (BNTX) Stock Valuation Questioned As Popular Narrative Signals Large Upside Potential
Moderna suing Pfizer for patent infringement in COVID-19 vaccine
Moderna: BioNTech is claiming work 'it never did'
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models
Is BioNTech SE (BNTX) A Good Stock To Buy Now?
Promising Biotech Stocks To Watch Today - June 11th - Daily Political
How New Lung Cancer Data for Pumitamig Could Reshape BioNTech's (BNTX) Post-Vaccine Investment Story
BioNTech (BNTX) and Bristol Myers Share New Results From ROSETTA Lung-02 Study
Havemeyer Place LP Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political
BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA
CenterBook Partners LP Grows Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political
Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)
Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative
Recent Analysts' Ratings Updates for BioNTech (BNTX) - Daily Political
How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO
BNTX: Leadership Upheaval And Oncology Trial Risks Will Pressure Expectations
BioNTech (NASDAQ:BNTX) Earns Buy Rating from Jefferies Financial Group
BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from Jefferies Financial Group - Stock Observer
Monaco Asset Management SAM Takes Position in BioNTech SE Sponsored ADR $BNTX
BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?
BNP Paribas Financial Markets Raises Stock Holdings in BioNTech SE Sponsored ADR $BNTX
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com
BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap
BNTX Upgraded by UBS -- Price Target Raised to $135
BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
